Feasibility of ecological momentary assessment to study depressive symptoms among cancer caregivers.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
05 2021
Historique:
received: 16 12 2020
accepted: 05 01 2021
pubmed: 13 1 2021
medline: 30 9 2021
entrez: 12 1 2021
Statut: ppublish

Résumé

Ecological momentary assessment (EMA) may help with the development of more targeted interventions for caregivers' depression, yet the use of this method has been limited among cancer caregivers. This study aimed to demonstrate the feasibility of EMA among cancer caregivers and the use of EMA data to understand affective correlates of caregiver depressive symptoms. Caregivers (N = 25) completed a depressive symptom assessment (Patient Health Questionnaire-8) and then received eight EMA survey prompts per day for 7 days. EMA surveys assessed affect on the orthogonal dimensions of valence and arousal. Participants completed feedback surveys regarding the EMA protocol at the conclusion of the week-long study. Of 32 caregivers approached, 25 enrolled and participated (78%), which exceeded the a priori feasibility cutoff of 55%. The prompt completion rate (59%, or 762 of 1,286 issued) did not exceed the a priori cutoff of 65%, although completion was not related to caregivers' age, employment status, physical health quality of life, caregiving stress, or depressive symptoms or the patients' care needs (ps > 0.22). Caregivers' feedback about their study experience was generally positive. Mixed-effects location scale modeling showed caregivers' higher depressive symptoms were related to overall higher reported negative affect and lower positive affect, but not to affective variability. Findings from this feasibility study refute potential concerns that an EMA design is too burdensome for distressed caregivers. Clinically, findings suggest the potential importance of not only strategies to reduce overall levels of negative affect, but also to increase opportunities for positive affect.

Identifiants

pubmed: 33432717
doi: 10.1002/pon.5627
pmc: PMC8931849
mid: NIHMS1782720
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-764

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003016
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003015
Pays : United States

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

J Clin Oncol. 2008 Dec 20;26(36):5890-5
pubmed: 19029423
Qual Life Res. 2018 Jul;27(7):1885-1891
pubmed: 29569016
CA Cancer J Clin. 2010 Sep-Oct;60(5):317-39
pubmed: 20709946
J Abnorm Psychol. 1982 Apr;91(2):87-95
pubmed: 7200102
Addict Behav. 2019 Jul;94:42-49
pubmed: 30181016
J Pers Soc Psychol. 2010 Dec;99(6):1042-60
pubmed: 20853980
J Consult Clin Psychol. 2014 Feb;82(1):1-8
pubmed: 24364792
Annu Rev Clin Psychol. 2008;4:1-32
pubmed: 18509902
Acta Psychiatr Scand. 2011 Oct;124(4):262-72
pubmed: 21838742
J Consult Clin Psychol. 2015 Aug;83(4):825-36
pubmed: 26009781
Int J Geriatr Psychiatry. 2017 Sep;32(9):949-958
pubmed: 27464472
Lancet Oncol. 2013 Jul;14(8):721-32
pubmed: 23759376
Support Care Cancer. 2014 Feb;22(2):435-44
pubmed: 24091719
Stat Med. 2012 Nov 30;31(27):3328-36
pubmed: 22419604
J Med Internet Res. 2017 Apr 26;19(4):e132
pubmed: 28446418
Eur J Oncol Nurs. 2012 Sep;16(4):387-98
pubmed: 22000812
Front Psychol. 2018 Oct 10;9:1843
pubmed: 30364167
Support Care Cancer. 2013 Mar;21(3):749-56
pubmed: 22933130
JMIR Aging. 2018 Dec 18;1(2):e11051
pubmed: 31518244
Assessment. 2022 Mar;29(2):136-151
pubmed: 32909448
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
J Stat Softw. 2013 Mar;52(12):1-38
pubmed: 23761062
Emotion. 2007 May;7(2):262-74
pubmed: 17516805
Clin Psychol Rev. 2012 Aug;32(6):510-23
pubmed: 22721999
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Cancer. 2016 Jul 1;122(13):1987-95
pubmed: 26991807
Addiction. 2019 Apr;114(4):609-619
pubmed: 30461120
Gerontologist. 1990 Oct;30(5):583-94
pubmed: 2276631
Psychooncology. 2017 Apr;26(4):428-437
pubmed: 27147198
Psychooncology. 1998 Jan-Feb;7(1):3-13
pubmed: 9516646
Psychooncology. 2013 Jul;22(7):1557-64
pubmed: 22941765

Auteurs

Kelly M Shaffer (KM)

Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.
Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.

Philip I Chow (PI)

Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.
Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.

Jillian V Glazer (JV)

Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.

Tri Le (T)

Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.
Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA.

Matthew J Reilley (MJ)

Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.
Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA.

Mark J Jameson (MJ)

Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, Virginia, USA.
Department of Otolaryngology, Division of Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, USA.

Lee M Ritterband (LM)

Department of Psychiatry and Neurobehavioral Sciences, Center for Behavioral Health and Technology, University of Virginia, Charlottesville, Virginia, USA.
Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH